OpenAI-Backed Chai Discovery Lands $130M to Accelerate AI Molecule Design

Chai Discovery, backed by OpenAI, raises $130M to accelerate AI-driven molecular design. Their Chai-2 platform achieves 16% success rate in developing functional antibodies, dramatically outperforming previous methods and promising breakthrough medical innovations.